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Recent evidence supports the notion that the endocannabinoid system may play a crucial role in neuroinflammation. We explored the
changes that some elements of this system exhibit in a macaque model of encephalitis induced by simian immunodeficiency virus. Our
results show that profound alterations in the distribution of specific components of the endocannabinoid system occur as a consequence
of the viral infection of the brain. Specifically, expression of cannabinoid receptors of the CB2 subtype was induced in the brains of
infected animals, mainly in perivascular macrophages, microglial nodules, and T-lymphocytes, most likely of the CD8 subtype. In
addition, the endogenous cannabinoid-degrading enzyme fatty acid amide hydrolase was overexpressed in perivascular astrocytes as
well as in astrocytic processes reaching cellular infiltrates. Finally, the pattern of CB1 receptor expression was not modified in the brains
of infected animals compared with that in control animals. These results resemble previous data obtained in Alzheimer’s disease human
tissue samples and suggest that the endocannabinoid system may participate in the development of human immunodeficiency virus-
induced encephalitis, because activation of CB2 receptors expressed by immune cells is likely to reduce their antiviral response and thus
could favor the CNS entry of infected monocytes.
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Introduction
Cannabinoid CB1 and CB2 receptors, endogenous ligands (“en-
docannabinoids”), degradative and synthesizing enzymes for
those ligands, and specific mechanisms for the termination of the
biochemical signal are the basic elements of the endocannabinoid
system (ECS) (Porter and Felder, 2001; Freund et al., 2003). It has
been hypothesized that the ECS participates in several key pro-
cesses that are related to, for instance, the control of motor activ-
ity, memory, reward, nociception, emesis, and endocrine func-
tions (Pertwee, 2000). Furthermore, a prominent role for this
system has been postulated in neuroprotection as well as in acute
and chronic neurodegeneration (Grundy et al., 2001; Mechou-
lam et al., 2002).
However, the pathophysiological role(s) of the ECS in the
CNS of higher mammals remains scarcely understood. Although
subtle differences exist, it is currently accepted that basic aspects
related to cannabinoid CB1 receptors and fatty acid amide hydro-
lase (FAAH) distributions in the human brain are in agreement
with those observed in the rat (Tsou et al., 1998b; Freund et al.,
2003). Cortical regions, basal ganglia structures, the hippocam-
pus, and the cerebellar cortex exhibit high levels of expression of
CB1 receptors and FAAH (Glass et al., 1997; Tsou et al., 1998a,b;
Romero et al., 2002). It is also important to note that because of
the massive postmortem generation of endocannabinoids
(Felder et al., 1996), few data exist on their levels in the human
CNS (Schabitz et al., 2002). Finally, the selective expression of
CB2 receptors in various immune cell types has been known since
their discovery in 1992 (Munro et al., 1993). It is currently ac-
cepted that the ECS, mainly through CB2 receptors, participates
in a wide variety of immune-related functions that range from
antigen processing to macrophage migration or B-cell differenti-
ation (Howlett et al., 2002).
Very recently, our group has reported that CB2 receptors are
present in both healthy brains (Nunez et al., 2004) and Alzhei-
mer’s disease (AD) brains (Benito et al., 2003). Thus, we have
described the presence of CB2 receptors in a discrete cellular sub-
population of brain macrophages, located on the external surface
of blood vessels, in the brains of control patients (Nunez et al.,
2004). These perivascular macrophages exhibit differential fea-
tures from other types of microglia and play important roles in
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blood– brain barrier functionality (Williams et al., 2001b). This
observation diverges from previous observations of rat and
mouse brains (Lynn and Herkenham, 1994; Howlett et al., 2002)
and suggests an additional role for the ECS in the human CNS. In
addition, CB2 receptor expression is induced in activated micro-
glial cells associated with deposits of -amyloid peptide in AD
(Benito et al., 2003). Additional experimental data also found
profound changes in FAAH distribution in AD tissue samples,
because both FAAH protein and enzymatic activity are signifi-
cantly increased in astrocytes surrounding -amyloid-enriched
plaques. Interestingly, no changes in CB1 receptor patterns of
distribution in AD samples were observed (Benito et al., 2003).
These observations suggest that the ECS undergoes dramatic
changes in degenerative processes associated with neuroinflam-
mation. This has led us to study the possible changes in specific
elements of the ECS in an animal model of encephalitis.
Materials and Methods
Animals and sampling. Necropsy brain specimens from rhesus macaques
(Macaca mulatta) with acquired immunodeficiency syndrome (AIDS)
and simian immunodeficiency virus (SIV)-induced encephalitis (SIVE)
(n  4), SIV-infected animals with AIDS and without encephalitis (n 
2), and one normal, uninfected control were used in this study. Animals
were inoculated with SIVmac251 (20 ng of SIV p27) by intravenous
injection. All infected animals were administered the CD8-depleting
monoclonal antibody cM-T807 (5 mg/kg, i.v.) on days 6, 8, and 10 after
infection. After the initial CD8 depletion, there is a rebound of CD8 T-
cells. In animals with or without CD8 depletion, nearly all T-cells in SIVE
brains are of the CD8 type (Kim et al., 2004). In this study, the main
reason for using the CD8 depletion paradigm was to induce more severe
encephalitis with a higher incidence. When the animals developed AIDS,
they were anesthetized with ketamine-HCl, killed by intravenous pento-
barbital overdose, and exsanguinated. CNS tissues were collected in 10%
neutral buffered formalin, embedded in paraffin, and cut into 5-m-
thick sections. The areas used in this study included frontal and parietal
cortices. We chose these structures based on the well known changes that
take place in these regions in SIVE, specifically in subcortical white
matter.
Immunohistochemistry. The protocol used for the immunohistochem-
ical staining is basically the same as described previously (Tsou et al.,
1998a; Benito et al., 2003), with slight modifications. Briefly, tissue sec-
tions were deparaffinized and washed extensively in 50 mM potassium-
PBS (KPBS), and endogenous peroxidase was blocked by incubation in
peroxidase-blocking solution (Dako, Glostrup, Denmark) for 20 min at
room temperature. To obtain a more efficient immunostaining, tissue
sections were subjected to an antigen retrieval procedure (Shi et al.,
2001). Briefly, sections were placed in a stainless-steel pressure cooker
containing a boiling solution (Antigen Retrieval Solution; Dako). After
heating under pressure for 2 min, samples were removed and washed
extensively in KPBS. Tissue sections were then incubated with the diverse
primary antibodies [rabbit polyclonal anti-CB1, 1:1000 dilution in KPBS;
rabbit polyclonal anti-CB2, 1:500 dilution in KPBS (both from Affinity
BioReagents, Golden, CO); and rabbit polyclonal anti-FAAH, 1:500 di-
lution in KPBS (Romero et al., 2002)]. The specificity of these antibodies
has been characterized previously (Romero et al., 2002; Benito et al.,
2003; Nunez et al., 2004). After 24 h of incubation at 4°C, sections were
washed in 50 mM KPBS and incubated with biotinylated goat anti-rabbit
antibody (1:200) at room temperature for 1 h followed by avidin– biotin
complex (Vector Elite; Vector Laboratories, Burlingame, CA), according
to the manufacturer’s instructions. Visible reaction product was pro-
duced by treating the sections with 0.04% diaminobenzidine (DAB)
(Dako) and 0.01% H2O2, dissolved in 0.1 M sodium acetate. Sections
were then dehydrated and sealed with coverslips. Controls for the immu-
nohistochemistry included preabsorption and coincubation of the anti-
bodies with the corresponding immunogenic proteins (CB1, fusion pro-
tein against amino acids 1–100 of human CB1 at 5 g/ml; CB2, fusion
protein against amino acids 1–33 of human CB2 at 5 g/ml; FAAH,
fusion protein against amino acids 561–579 of rat FAAH at 1.25 g/ml)
and incubation in the absence of primary antibody. Sections adjacent to
those used in the immunohistochemical studies were used for hematox-
ylin and Nissl stainings. A Nikon (Tokyo, Japan) Eclipse 90i microscope
and DXM1200F camera were used for the observations and photography
of the slides, respectively.
Immunofluorescence. To obtain complete identification of the cellular
types exhibiting FAAH or CB2 immunostainings, double-labeling studies
were performed. The phenotypic markers used were as follows: glial
fibrillary acidic protein (GFAP) as a prototypic marker for astrocytes
(monoclonal mouse anti-human GFAP; 1:100 dilution; Dako); CD68 as
a macrophage/microglia marker (monoclonal mouse anti-human CD68;
1:100 dilution; Dako); and CD3 as a T-lymphocyte marker (monoclonal
mouse anti-human CD3; 1:50 dilution; Dako). We have demonstrated
recently that essentially all of the CD3-positive T-cells in the brains of
SIV-infected animals with SIVE are CD8 T-cells (Kim et al., 2004). The
protocol included two consecutive steps: immunostaining with one of
the markers mentioned and chromogenic reaction with DAB, followed
by immunofluorescence with anti-CB2 antibody, as described previously
(Nunez et al., 2004).
For FAAH/GFAP colocalization, the described protocol (see above)
was performed for FAAH staining by using a secondary biotinylated
antibody followed by avidin– biotin amplification (Vector Laboratories)
and DAB as chromogen. After extensive washes, sections were incubated
with the anti-GFAP antibody for 24 h at 4°C, followed by incubation with
an Alexa 488 anti-mouse antibody conjugate (Molecular Probes, Eugene,
OR), rendering green fluorescence.
For CB2/CD68 and CB2/CD3 colocalizations, the EnVision system
(Dako) was used to visualize the presence of microglia and
T-lymphocytes, respectively, using DAB as chromogen, thus rendering
brown color. Afterward, samples were incubated with anti-CB2 antibody,
subsequently incubated with biotinylated anti-rabbit secondary anti-
body, and finally incubated with Alexa 488-streptavidin conjugate (Mo-
lecular Probes), rendering green fluorescence. A Nikon Eclipse 90i mi-
croscope and DXM1200F camera were used for the observations and
photography of the slides, respectively.
Western blotting. Protein extracts were prepared from frontal cortices
of one uninfected control and two SIVE monkeys that were used for
immunohistochemistry. Tissues were homogenized in lysis buffer (50
mM Tris-HCl, pH 8.0, 150 mM NaCl, 1% NP-40) with 1 protease in-
hibitor mixture (Roche Products, Welwyn Garden City, UK). The ho-
mogenate was incubated on ice for 30 min and then centrifuged at
10,000  g for 30 min at 4°C. The supernatant was collected, and protein
concentration was determined using the BCA protein assay kit (Pierce,
Rockford, IL). Twenty-five micrograms of protein extract from each
sample were reduced and denatured and separated by electrophoresis
through a 4 –15% gradient polyacrylamide preparative gel. The proteins
were transferred from the gel to Immuno-Blot polyvinylidene difluoride
membrane (Bio-Rad, Hercules, CA). The membrane was washed with
TBS containing 0.1% Tween 20 (TBST) and blocked in TBST containing
5% dry goat milk. Primary antibody was diluted in TBST containing 5%
dry goat milk at 1:2000 for CB1; this was incubated overnight at 4°C with
gentle shaking. Blots were washed four times in TBST and then incubated
with goat anti-rabbit HRP (1:1000; Dako) for 1 h at room temperature.
The membrane was washed four times in TBST. Finally, the immune
complex was visualized using an ECL Western Blotting kit (Amersham
Biosciences, Arlington Heights, IL). The specificity of the signal was con-
firmed by preincubation with the immunizing peptide (1:900).
Results
Although no significant changes could be seen among control
and SIV animals with AIDS and without encephalitis, clear dif-
ferences were evident in the pattern of expression of some ele-
ments of the ECS in the brains of SIVE animals. For this reason,
joint data from control and SIV animals without encephalitis are
presented herein and compared with those from SIVE animals.
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CB1 receptors
CB1 receptors were distributed homogeneously throughout the
neuropil of the macaque cortex both in control and in SIVE an-
imals (Fig. 1). In addition, cell bodies of pyramidal neurons were
moderately stained, whereas no CB1 immunoreactivity was ob-
served in white matter areas or in perivascular infiltrates (Fig.
1B). Finally, no significant changes were noticed in the pattern of
expression and/or in the amount of CB1 protein (Fig. 2) between
control and SIVE samples.
CB2 receptors
Although no significant staining was observed in tissue samples
from control animals (Fig. 3A), an intense level of immunolabel-
ing could be seen in SIVE animals. This signal was circumscribed
to discrete cell populations. Specifically, perivascularly located
cells exhibited the highest levels of staining (Fig. 3B), and remark-
ably some cells were also stained in white matter areas. These
CB2-positive cells surround the external surface of almost all
blood vessels, independent of the diameter of the vessels (Fig.
3B–D). In addition, CB2 immunostaining could be observed in
cells located within cellular infiltrates (Fig. 3E,F). This signal
corresponded to grouped cells and was limited to cellular infil-
trates surrounding blood vessel walls, which is a well character-
ized feature of SIVE brains.
To define the specific cell type(s) expressing CB2 receptors in
SIVE animal tissue sections, double-labeling experiments were
performed. To that end, two well known phenotypic markers
were used: CD3 receptor (a marker for T-lymphocytes) and
CD68 antigen (a marker for macrophages/microglia). Results ob-
tained by this experimental approach allowed us to identify
perivascular microglia and T-lymphocytes as CB2-expressing
cells. Thus, CD68-positive cells located on the external surface of
blood vessels as well as in perivascular cellular infiltrates also
expressed CB2 receptors (Fig. 4A–D). Additionally, cell groups
including numerous CD3-positive cells in SIVE lesions were also
CB2 positive, thus indicating the presence of this subtype of can-
nabinoid receptor in T-lymphocytes (Fig. 4E,F). We have re-
cently performed extensive double-label immunohistochemistry
and found that most of the CD3 T-cells in the CNS are of the CD8
Figure 1. CB1 immunoreactivity in brain tissue samples of frontal cortex from control (A) and
SIVE (B) animals. In both groups, a moderate signal could be observed in pyramidal neurons (A,
inset) together with a diffuse neuropilic labeling. No significant modifications were observed in
SIVE animals even within cellular infiltrates in white matter areas (B, inset). Scale bars: A, B, 400
m; insets, 200 m.
Figure 2. Western blot of CB1 immunoreactivity in cortical tissue homogenates from control
(A, lane 1) and SIVE (A, lane 2) animals. Two bands of 85 and 52 kDa were detected. Preincuba-
tion with the immunizing peptide completely prevented the signal in control (B, lane 1) and
SIVE (B, lane 2) samples.
Figure 3. CB2 staining in brain cortical tissue samples of the frontal cortex from control (A)
and SIVE (B–F ) animals. A, Note the absence of any detectable signal in tissue sections from
control animals compared with SIVE animals (B). B, Selected cells on a perivascular location
show strong immunoreactivity for CB2 receptors. Longitudinal (C) and transverse (D) sections of
blood vessels show intense signal in the outer surface of the vessel walls. E, CB2-positive cells
within cellular infiltrates commonly found in perivascular areas of SIVE brains. Cells located both
on incipient microglial nodules (arrows) and on well developed, mature infiltrates (dashed
circle) show CB2 labeling. F, High-magnification image of an incipient infiltrate in the proximity
of a blood vessel wall (asterisk) showing CB2 immunoreactivity (brown color). Scale bars: E, 800
m; A, B, 400 m; C, 200 m; D, F, 100 m.
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T-cell subset (Kim et al., 2004), suggesting that these CD8-
positive cells are also expressing CB2 receptors.
FAAH
Cortical gray matter regions of control and SIVE macaques
showed medium to intense immunoreactivity for FAAH (Fig. 5).
Pyramidal neurons exhibited a strong signal in cell bodies. Inter-
estingly, a clear perinuclear reinforcement could be noticed,
whereas dendrites and axons were weakly stained; this resembles
previous data obtained in human samples (data not shown) (Ro-
mero et al., 2002).
Dramatic changes were apparent in white matter areas of the
cortex, an area known to suffer extensive astrogliosis in SIVE and
human immunodeficiency virus (HIV)-induced encephalitis
(HIVE). Thus, although no staining for FAAH was observed in
white matter from control animals, strong immunoreactivity was
detected in those with SIVE (Fig. 5B–F). This signal was present
in astrocytes, as demonstrated by double staining with GFAP
(Fig. 5E,F). Specifically, astrocytes surrounding perivascular cel-
lular infiltrates showed high levels of FAAH immunostaining, in
contrast to those surrounding vessels lacking pathological infil-
trates, which showed only a moderate staining (Fig. 5C).
Discussion
We have studied the effects of brain infection by the simian im-
munodeficiency virus, a lentivirus that shares many similarities
with HIV-1 (Lackner, 1994; Whetter et al., 1999; Nath et al.,
2000). Brain infection by these viruses is thought to produce
Figure 4. CB2 receptors are expressed by microglial cells associated with blood vessels (A, B)
as well as in pathological cellular infiltrates (C, D) and by T-lymphocytes (E, F ). A, Immunoflu-
orescent signal for CB2 receptors is located in the outer portion of a blood vessel. B, CD68
immunoreactivity (a common marker of macrophages/microglia) in the same vessel shown in
A. Note the partial overlap of CB2 and CD68 staining. C, Immunofluorescent signal for CB2
receptors in groups of perivascular cells. D, The same groups of cells were positive for CD68
staining. E, F, Cellular infiltrates show strong immunoreactivity for CB2 (E) and CD3 (F ). Note the
almost total match between both patterns. Scale bars, 50 m.
Figure 5. FAAH immunoreactivity in brain cortical tissue samples of the frontal cortex from
control (A) and SIVE (B–F ) animals. A, FAAH staining in control animals was limited to gray
matter (Gm) portions of the cortex, specifically in pyramidal neurons (inset). Note the almost
complete absence of labeling in white matter areas (Wm). B, FAAH immunoreactivity in SIVE
was dramatically increased in white matter areas of the cortex. This increased signal corre-
sponded to the astrogliotic process characteristic of SIVE. C, D, FAAH is massively expressed in
white matter astrocytes and, remarkably, in those associated with blood vessels (C, asterisks)
having perivascular infiltrates (arrows). Interestingly, a lesser degree of expression seemed to
occur around those vessels lacking these pathological structures (C, white arrow). FAAH immu-
noreactivity was present both in somata and in astrocytic processes. E, F, FAAH immunoreac-
tivity (black arrows) colocalizes with GFAP-positive cells (white arrows), confirming their astro-
cytic nature. Scale bars: A, B, 800 m; C, 200 m; insets in A, D, 100 m; E, F, 50 m.
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long-term damaging effects, including cognitive impairment and
disruption of motor capabilities (Kolson et al., 1998; Kolson and
Gonzalez-Scarano, 2000; Williams and Hickey, 2002). The SIVE
model is considered a good experimental approach to the study
of human disease because it mimics many of its principal hall-
marks (Petry and Luke, 1997).
In humans, a subset of HIV-infected patients with dementia
exhibit neuropathological changes, termed HIVE, in which mi-
croglial and astroglial cells play a pivotal role (Kolson and
Gonzalez-Scarano, 2000; Kaul et al., 2001). HIVE is caused by a
viral infection of the brain that targets perivascular brain macro-
phages (Williams et al., 2001a). Histopathology includes acti-
vated brain macrophages and astrocytes, inflammatory cuffs of
monocyte/macrophages, some of which are infected, activated
astrocytes, and inflammatory CD8 T-lymphocytes. Because neu-
rons themselves are not infected directly, neuronal injury is
thought to occur via indirect mechanisms by factors released
from activated macrophages and astrocytes.
We report the existence of profound changes in the distribu-
tion pattern of cannabinoid CB2 and FAAH proteins in cortical
regions of macaque brains affected by SIVE. These results fit well
with those that we have observed previously in AD tissue samples
(Benito et al., 2003) in that (1) they show dramatic changes in the
distribution of several components of the ECS, (2) these changes
affect mainly FAAH and CB2 receptors and not CB1, (3) the ob-
served changes seem to be related to the inflammatory process
characteristic of SIVE, and (4) a clear cellular selectivity exists for
these changes, because FAAH is overexpressed in astrocytes,
whereas CB2 receptors are expressed abundantly in perivascular
microglial cells as well as in microglial nodules and infiltrated
lymphocytes. These results allow us to postulate some elements of
the ECS as markers for CNS inflammation and confirm our pre-
vious observations in AD, which show that an endocannabinoid
glial system is upregulated in vivo under inflammatory conditions
(Pazos et al., 2004). Furthermore, the similarities between FAAH
and CB2 changes of expression in glial cells in SIVE and those
observed in AD tissue samples suggest a common pattern of re-
sponse, independent of the type of primary inflammatory insult.
The present data indicate that CB1 receptors remain un-
changed in SIVE brains with respect to control brains and their
presence is limited to neuronal elements of the cortex, as revealed
by Western blotting and immunohistochemistry. This is in con-
cordance with our previous data in human AD tissue samples
(Benito et al., 2003) and seems to rule out a direct role for this
subtype of cannabinoid receptors in the SIV-induced inflamma-
tory reaction. It must be emphasized, however, that CB1 stimu-
lation has been shown to confer neuroprotection and promote
neuronal cell survival under different experimental paradigms
(Guzman et al., 2002; Mechoulam et al., 2002), and thus a possi-
ble protective role for them in SIVE may be postulated. It is
known that SIV and HIV do not infect neurons directly but in-
stead productively infect microglial cells and macrophages,
which then produce neurotoxic substances that ultimately kill
neurons through a series of mechanisms including excitotoxicity,
oxidative stress, and increases in Ca 2 levels (Kaul et al., 2001).
All of these deleterious effects are known to be partially counter-
acted by CB1 activation (Van der Stelt et al., 2002). Interestingly,
Maccarrone et al. (2004) have reported that a decrease in anand-
amide (a CB1 partial agonist) levels may be associated with the
neurotoxicity caused by gp120 protein, one of the main virotox-
ins of HIV.
On the other hand, the results presented herein indicate that
cannabinoid CB2 receptors may play a critical role in CNS in-
flammation. Their presence in perivascular microglial cells as
well as in microglial nodules and in lymphocytes of the T type
strongly suggests their involvement in several aspects of SIVE.
First, we report that CB2 expression is induced in perivascular
microglia as a consequence of viral infection, because control
brains do not show CB2 immunoreactivity. This observation is in
contrast with our previous data in control human brains that
showed CB2-positive immunostaining in perivascular macro-
phages. As suggested in our previous work (Nunez et al., 2004),
this could reflect an interspecies variation in the pattern of CB2
expression or an agonal/postmortem induction of CB2 expres-
sion in the human CNS. In any case, selective CB2 expression in
this specific type of microglial cell suggests that this receptor may
play a prominent role in the process of viral entry into the CNS,
because perivascular microglia have been shown to be a cell type
that is significantly involved in this process (Williams et al.,
2001b). In this sense, it must also be emphasized that Croxford
and Miller (2003) showed that viral load in the CNS is increased
in the brains of mice inoculated with the Theiler virus, a murine
model of multiple sclerosis, after treatment with the synthetic
cannabinoid WIN55,212-2, a mixed CB1/CB2 agonist (Howlett et
al., 2002).
Second, it is not surprising that CB2 receptors are present in
microglial nodules. These cellular accumulations are one of the
hallmarks of SIVE and HIVE. In addition, CB2 activation is cur-
rently considered a major factor in microglial function (Walter et
al., 2003; Carrier et al., 2004) and, remarkably, has been shown to
mediate the production of chemotactic substances for monocytes
that are key factors in their recruitment into the brain. Klegeris et
al. (2003) have reported that CB2 agonists decrease the produc-
tion of proinflammatory substances by an activated human mi-
croglial cell line. Conversely, two groups have shown recently that
CB2 activation also promotes microglial migration and prolifer-
ation (Walter et al., 2003; Carrier et al., 2004). Furthermore, CB2
activation enhances human macrophage-like and peripheral
blood monocyte migration after CB2 activation (Derocq et al.,
2000; Kishimoto et al., 2003).
Third, to our knowledge, this report is the first showing that
CB2 receptors are present in peripheral cells that have infiltrated
the CNS as a consequence of a pathological process. We demon-
strate here that T-lymphocytes express this receptor in SIVE
brains as a consequence of the viral CNS infection. Lymphocyte
infiltration in tissues is a common feature in many forms of in-
flammation, and specifically in viral encephalitis, for which we
and others have demonstrated a significant accumulation of
CD8-positive T-lymphocytes that are likely SIV antigen specific
(Kim et al., 2004). Although no conclusive data exist on the role
of CB2 receptors in lymphocyte function (Grundy et al., 2001),
these receptors are known to be expressed by peripheral
T-lymphocytes, although in low levels. Their presence in these
cells in the brains of SIVE animals is highly suggestive of a prom-
inent role in CNS infiltration and could be a consequence of an
upregulation process linked to brain invasion by these cells. In
this sense, regulation of CB2 expression under different patho-
physiological conditions has been reported previously in other
experimental paradigms (Sanchez et al., 2001; Jorda et al., 2003).
Additional experiments should clarify this point.
Finally, a remarkable selectivity for FAAH expression in astro-
cytes was observed in SIVE samples. This feature matches well
with previous data from AD human samples in which FAAH
expression and activity were greatly enhanced in astrocytes lo-
cated in the vicinity of neuritic plaques. Although tissue samples
from control animals exhibited a wide distribution of FAAH in
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principal neurons of the cortex (mainly pyramidal neurons), a
massive expression of this enzyme in hypertrophied astrocytes
was evident in SIVE samples. Furthermore, FAAH-positive astro-
cytes were found predominantly in perivascular regions and spe-
cifically in areas of cellular infiltration. It is currently thought that
astrocytes become hypertrophied and hyperplastic in those brain
regions in which an inflammatory process takes place and specif-
ically that astrocytic processes densely infiltrate these areas as part
of a concerted anti-inflammatory endogenous response (Wyss-
Coray and Mucke, 2002). In our opinion, the presence of FAAH
in these cells is highly suggestive of a direct involvement of FAAH
in the inflammatory process linked to SIVE. In addition, astro-
cytes are known to play a regulatory role in HIV-1 encephalitis by
dampening the overexpression of eicosanoids, platelet-activating
factor, and tumor necrosis factor- by activated HIV-1 mono-
cytes (Minagar et al., 2002); FAAH overexpressed in glial cells
could partially counteract some of these beneficial processes
(Weber et al., 2004).
In summary, we report the existence of profound alterations
in the pattern of expression of CB2 receptors and FAAH in the
brain of macaques with SIVE. These changes are linked to the
inflammatory process and suggest a prominent role for the ECS
in glial activation under pathological conditions.
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